Pampa Energia S.A. (ADR) (PAM) Reaches $62.56 52-Week High; Per Se Technologies Has 0.5 Sentiment

May 25, 2017 - By Vivian Currie

The stock of Pampa Energia S.A. (ADR) (NYSE:PAM) hit a new 52-week high and has $66.31 target or 6.00% above today’s $62.56 share price. The 8 months bullish chart indicates low risk for the $4.69 billion company. The 1-year high was reported on May, 25 by Barchart.com. If the $66.31 price target is reached, the company will be worth $281.40M more. About 44,859 shares traded. Pampa Energia S.A. (ADR) (NYSE:PAM) has risen 176.38% since May 25, 2016 and is uptrending. It has outperformed by 159.68% the S&P500.

Pluristem Therapeutics Inc. is a developer of placenta cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The company has market cap of $132.74 million. The Company’s lead indications are critical limb ischemia , recovery after surgery for femoral neck fracture and acute radiation syndrome. It currently has negative earnings. The Company’s activities are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies.

Pampa Energia S.A. is an integrated electricity company. The company has market cap of $4.69 billion. The Company, through its subsidiaries, is engaged in the generation, transmission and distribution of electricity in Argentina. It has a 59.85 P/E ratio. The Company’s divisions include generation, transmission, distribution, gas and oil, and holding and others.

About 16,396 shares traded. Pluristem Therapeutics Inc. (PSTI) has declined 7.80% since May 25, 2016 and is downtrending. It has underperformed by 24.50% the S&P500.

Oppenheimer & Co Inc holds 0.01% of its portfolio in Pluristem Therapeutics Inc. for 127,000 shares. Bank Of America Corp De owns 125 shares or 0% of their US portfolio. Moreover, California Public Employees Retirement System has 0% invested in the company for 181,700 shares. The Illinois-based Citadel Advisors Llc has invested 0% in the stock. Citigroup Inc, a New York-based fund reported 1,040 shares.